TrialRespiratory research2020

Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis.

Mona Bafadhel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.